相关实验视频
Updated: May 16, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
USP5二基化和稳定IMPDH2,以促进肝细胞癌的进展
Shuoyi Jiang1, Liyang Jiang2,3, Yingying Xu1
1NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China.
乌比基特异性蛋白酶5 (USP5) 通过稳定IMPDH2.2促进肝细胞癌 (HCC). 针对USP5-IMPDH2轴可能为HCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 调节deubiquitinase活动是一种有前途的癌症治疗方法.
- 乌比基特异性蛋白酶5 (USP5) 在肝细胞癌 (HCC) 中过度表达,并与患者预后不佳有关.
研究的目的:
- 调查USP5及其与因诺辛单酸脱酶2 (IMPDH2) 相互作用在HCC进展中的作用.
- 探索针对USP5-IMPDH2轴在HCC中的治疗潜力.
主要方法:
- 确定IMPDH2作为USP5的约束性合作伙伴.
- 研究了USP5在IMPDH2.2上的二基因酶活性.
- 评估了USP5-IMPDH2轴对HCC扩散,转移和上皮-介质细胞过渡 (EMT) 的影响.
- 评估了USP5抑制剂WP1130和IMPDH2降低与sorafenib结合的疗效.
主要成果:
- USP5二基化IMPDH2,防止其降解并使其稳定.
- USP5-IMPDH2轴通过EMT促进HCC的扩散和转移.
- USP5诱导的HCC进展涉及GTP生物合成途径.
- 在HCC模型中,USP5抑制或IMPDH2降低增强了索拉芬尼的抗瘤作用.
结论:
- IMPDH2是USP5的基质,这种相互作用驱动HCC的进展.
- 针对USP5-IMPDH2轴为HCC.提供了一个潜在的治疗策略.
更多相关视频
10:26Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
09:40Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
相关概念视频
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Hedgehog Signaling Pathway
Anaphase Promoting Complex
Export of Misfolded Proteins out of the ER
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...